Andrew Moreno

Andrew is a native of Connecticut and attended Eastern Connecticut State University to study biochemistry. While working on antibody engineering at Alexion Pharmaceuticals, Andrew became fascinated with the physical properties of macromolecular interactions and decided to attend graduate school at Wesleyan University to pursue this interest. There he worked with Professor Ishita Mukerji on projects involving the photochemistry of fluorescent base analogs and the nature of protein-DNA interactions. After a short post-doctoral position in the Wade lab at John Hopkins School of Medicine where his focus was on the rules governing promiscuous ligand recognition by multi-drug resistance proteins, he moved back north to Boston to join the Loparo Lab to work on developing a molecular model for non-homologous end-joining, a DNA double-strand break repair mechanism.